{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:01:20Z","timestamp":1790924480233,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1136\/ard.2003.008623","type":"journal-article","created":{"date-parts":[[2004,3,13]],"date-time":"2004-03-13T02:12:57Z","timestamp":1079143977000},"page":"415-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases"],"prefix":"10.1016","volume":"63","author":[{"given":"S","family":"Dubucquoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Solau-Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Lefranc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Marguerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Dutoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-L","family":"Fauchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R-M","family":"Flipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Prin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2003.008623_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/art.10092","article-title":"Treating rheumatoid arthritis early: a window of opportunity?","volume":"46","author":"O\u2019Dell","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","article-title":"How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis","volume":"46","author":"Visser","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI116713","article-title":"The cytokeratin filament-aggregating protein filaggrin is the target of the so-called \u201cantikeratin antibodies,\u201d autoantibodies specific for rheumatoid arthritis","volume":"92","author":"Simon","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2003.008623_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2003.008623_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.2003.008623_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib8","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin","volume":"166","author":"Masson-Bessiere","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.2003.008623_bib9","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/rheumatology\/39.10.1082","article-title":"Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis","volume":"39","author":"Bas","year":"2000","journal-title":"Rheumatology (Oxf)"},{"key":"10.1136\/ard.2003.008623_bib10","first-page":"745A","article-title":"The role of HLA-DRB1*0401 MHC class II in autoimmune response to citrullinated antigens [abstract]","volume":"46","author":"Hill","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib11","first-page":"746A","article-title":"Citrullinated vimentin and fibrinogen peptides activate CD4+ T cells in HLA-DRB1*0401 transgenic mice [abstract]","volume":"46","author":"Hill","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib12","first-page":"276","article-title":"Improvement in diagnosis of rheumatoid arthritis using dual indirect immunofluorescence and immunoblotting assays for antifilaggrin autoantibodies: a retrospective 3 year study","volume":"29","author":"Ferraro-Peyret","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.008623_bib13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.008623_bib14","first-page":"2208","article-title":"Patients with rheumatoid arthritis benefit from early second line therapy: 5 year followup of a prospective double blind placebo controlled study","volume":"22","author":"Egsmose","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.008623_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-124-8-199604150-00001","article-title":"The effectiveness of early treatment with \u201csecond-line\u201d antirheumatic drugs. A randomized, controlled trial","volume":"124","author":"van der Heide","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2003.008623_bib16","first-page":"1072","article-title":"Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well","volume":"25","author":"Symmons","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.008623_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","article-title":"Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration","volume":"43","author":"Anderson","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib18","first-page":"243","article-title":"Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine","volume":"20","author":"Buckland-Wright","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.008623_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.57.2.88","article-title":"Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study","volume":"57","author":"Munro","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.008623_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/art.1790110204","article-title":"A comparison of IgM rheumatoid factor by nephelometry and latex methods: clinical and laboratory significance","volume":"11","author":"Wolfe","year":"1998","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard.2003.008623_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/096120330000900111","article-title":"Primary Sjogren\u2019s syndrome in men: clinical and immunological characteristics","volume":"9","author":"Cervera","year":"2000","journal-title":"Lupus"},{"key":"10.1136\/ard.2003.008623_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/rheumatology\/35.7.620","article-title":"Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor","volume":"35","author":"Cordonnier","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2003.008623_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/ard.60.5.459","article-title":"Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis","volume":"60","author":"Vasiliauskiene","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.008623_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","article-title":"Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset","volume":"2","author":"Goldbach-Mansky","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.2003.008623_bib25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","article-title":"The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis","volume":"43","author":"Kroot","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","article-title":"Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis","volume":"47","author":"Bizzaro","year":"2001","journal-title":"Clin Chem"},{"key":"10.1136\/ard.2003.008623_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","article-title":"Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage","volume":"62","author":"Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.008623_bib28","first-page":"127","article-title":"Rheumatoid arthritis and filaggrin. A review","volume":"62","author":"Berthelot","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1136\/ard.2003.008623_bib29","first-page":"847","article-title":"Diagnostic value of antibodies to filaggrin in rheumatoid arthritis","volume":"25","author":"Slack","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.008623_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ard.58.1.42","article-title":"Anti-perinuclear factor compared with the so called \u201cantikeratin\u201d antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides","volume":"58","author":"Vincent","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.008623_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.10241","article-title":"Value of laboratory tests in early prediction of rheumatoid arthritis","volume":"47","author":"Saraux","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib32","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.10229","article-title":"Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay","volume":"46","author":"Union","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.008623_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/ard.62.3.261","article-title":"Filaggrin related antibodies among the aged","volume":"62","author":"Palosuo","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.008623_bib34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/rheumatology\/41.7.809","article-title":"Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors","volume":"41","author":"Bas","year":"2002","journal-title":"Rheumatology (Oxf)"},{"key":"10.1136\/ard.2003.008623_bib35","first-page":"34","article-title":"Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies","volume":"21","author":"Vasishta","year":"2002","journal-title":"Am Clin Lab"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724083365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724083365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2003.008623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:54:01Z","timestamp":1737348841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724083365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0003496724083365"],"URL":"https:\/\/doi.org\/10.1136\/ard.2003.008623","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2003.008623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Copyright 2004 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}